- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Tumor microenvironment and immunotherapy for triple-negative breast cancer ; volume:12 ; number:1 ; day:31 ; month:12 ; year:2024 ; pages:1-19 ; date:12.2024
Biomarker Research ; 12, Heft 1 (31.12.2024), 1-19, 12.2024
- Urheber
-
Guo, Zijie
Zhu, Ziyu
Lin, Xixi
Wang, Shenkangle
Wen, Yihong
Wang, Linbo
Zhi, Lili
Zhou, Jichun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40364-024-00714-6
- URN
-
urn:nbn:de:101:1-2503072118419.133109573780
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Guo, Zijie
- Zhu, Ziyu
- Lin, Xixi
- Wang, Shenkangle
- Wen, Yihong
- Wang, Linbo
- Zhi, Lili
- Zhou, Jichun
- SpringerLink (Online service)
Ähnliche Objekte (12)
Advances in immunotherapy for triple-negative breast cancer
Immunotherapy in Triple-Negative Breast Cancer: Present and Future
Correction: Advances in immunotherapy for triple-negative breast cancer
Clinical trials of immunotherapy in triple-negative breast cancer
Spatial predictors of immunotherapy response in triple-negative breast cancer
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
Metastatic Triple-Negative Breast Cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Caspase-1-dependent spatiality in triple-negative breast cancer and response to immunotherapy
TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis
The potent potential of MFAP2 in prognosis and immunotherapy of triple-negative breast cancer
Advances in immunotherapy for triple-negative breast cancer
Immunotherapy in Triple-Negative Breast Cancer: Present and Future
Correction: Advances in immunotherapy for triple-negative breast cancer
Clinical trials of immunotherapy in triple-negative breast cancer
Spatial predictors of immunotherapy response in triple-negative breast cancer
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
Metastatic Triple-Negative Breast Cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Caspase-1-dependent spatiality in triple-negative breast cancer and response to immunotherapy
TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis
The potent potential of MFAP2 in prognosis and immunotherapy of triple-negative breast cancer
Advances in immunotherapy for triple-negative breast cancer
Immunotherapy in Triple-Negative Breast Cancer: Present and Future
Correction: Advances in immunotherapy for triple-negative breast cancer
Clinical trials of immunotherapy in triple-negative breast cancer
Spatial predictors of immunotherapy response in triple-negative breast cancer
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
Metastatic Triple-Negative Breast Cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Caspase-1-dependent spatiality in triple-negative breast cancer and response to immunotherapy
TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis